IART INTEGRA LIFESCIENCES HOLDINGS CORP

Last updated: Mar 17, 2026

—

Execution Consistency

Did the company actually spend money buying back stock in 3+ of the last 4 quarters?

Bought back stock in 2/4 quarters. Q3 2025: $0M, Q3 2024: $125M, Q2 2024: $0M, Q1 2024: $150M

🐻

Is the most recent quarter's buyback spend more than 15% above the trailing average?

Latest quarter $0M vs trailing avg $92M (-100%)

—

What percentage of free cash flow is going to buybacks? Bull: 30-80%. Bear: <10% or >80%.

Negative FCF ($-185M), cannot compute buyback ratio

🐂

How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.

Repurchased 5,200,000 shares = 6.7% of 77,892,111 outstanding (annualized)

🐂

Are officers and directors buying stock with their own money on the open market?

5 open-market purchases by 5 insiders

GRAVES JEFFREY A () bought 9,000 shares at $11.35 on 2025-11-05
ESSIG STUART (Exec. Chairman of the Board) bought 52,641 shares at $28.49 on 2024-05-23
HILL BARBARA B () bought 36,350 shares at $27.40 on 2024-05-21
Schwartz Eric (EVP, Chief Legal Officer & Sec) bought 2,640 shares at $37.89 on 2023-06-01
De Witte Jan (President & CEO) bought 7,792 shares at $38.50 on 2023-06-01

—

Are insider purchases happening during the same quarters the company is actively buying back stock?

Insider buying coincided with company buybacks in 1 of 4 quarters

🐻

Looking at all open-market transactions, are insiders net buyers or net sellers?

Insiders bought $3M, sold $145M (net selling)

🚩

Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.

Company buying back stock while insiders sold 48.2x more than bought. 6 C-suite officers among sellers